Connection

JASON ROBERT WESTIN to Gene Expression Regulation, Neoplastic

This is a "connection" page, showing publications JASON ROBERT WESTIN has written about Gene Expression Regulation, Neoplastic.
  1. Vive la r?sistance: stem cells in mantle cell lymphoma. Leuk Lymphoma. 2011 Jun; 52(6):944-5.
    View in: PubMed
    Score: 0.127
  2. Status of PI3K/Akt/mTOR pathway inhibitors in lymphoma. Clin Lymphoma Myeloma Leuk. 2014 Oct; 14(5):335-42.
    View in: PubMed
    Score: 0.039
  3. Targetable genetic alterations of TCF4 (E2-2) drive immunoglobulin expression in diffuse large B cell lymphoma. Sci Transl Med. 2019 06 19; 11(497).
    View in: PubMed
    Score: 0.014
  4. Immune Profiling and Quantitative Analysis Decipher the Clinical Role of Immune-Checkpoint Expression in the Tumor Immune Microenvironment of DLBCL. Cancer Immunol Res. 2019 04; 7(4):644-657.
    View in: PubMed
    Score: 0.014
  5. Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas. Clin Cancer Res. 2018 08 15; 24(16):3967-3980.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.